Clinical Reach is an end-to-end patient centric technology platform, enabling enrollment, engagement, and reporting for clinical trials worldwide.

San Diego, California (PRWEB) October 22, 2015

Parallel 6, a SaaS provider of mobile enrollment and engagement solutions, announced today that Brad Pruitt, M.D., MBA joined Parallel 6 as their Chief Medical Officer. Dr. Pruitt is shaping product innovation for Clinical Reach, which is an enterprise-strength, technology platform that enrolls, engages, informs, and reports on clinical trial participants anywhere in the world. The Clinical Reach platform also provides real-time clinical operational metrics to aid in driving clinical trial efficiencies.

“We are excited to have Dr. Pruitt join the Parallel 6 team,” said President, CTO and Founder of Parallel 6, David Turner. “His experience writing protocols for mHealth technologies and working with large, multinational studies, hospitals, and clinical trial sites will be an asset to our team. Our people, process and technology is what enables us to disrupt the market, and make a positive impact on clinical trials for the good of the patient.”

Dr. Pruitt joins Parallel 6 with over eighteen years of experience working with clients, and partners in healthcare-related technology organizations in the U.S. and Latin America. Dr. Pruitt’s primary expertise is in furthering digital health IT and mobile solutions for telemedicine, clinical trials, mHealth, and remote patient monitoring.

“I’ve been in the healthcare and life sciences industry for more than 18 years, and I strive to find new ways to innovate and disrupt the industry," said Dr. Pruitt, CMO for Parallel 6. "My enthusiasm to join Parallel 6 is rooted in the opportunity to enhance the Clinical Reach platform. Clinical Reach is advancing the life sciences industry by providing a platform to enroll, engage, inform and report real-time data for clinical trials. As a contributor to the Parallel 6 leadership team, my goal is to progress our innovative technology and bring new and potentially life saving treatments to market faster.”

Dr. Pruitt has consulted with innovative mHealth and clinical technology firms such as AirStrip, EndoStim, Sotera and McKesson. As a seasoned entrepreneur, Dr. Pruitt’s background also includes founding patient recruitment startup nPruv. At nPruv, Dr. Pruitt built recruitment technologies for online recruitment and in-clinic recruitment workflow.

To learn how Clinical Reach is leading technical innovation for clinical trials, visit http://www.parallel6.com or request a demo.

###

About Parallel 6
Parallel 6, is an innovative software as a service provider of mobile enrollment & engagement solutions for clinical research, health, & public sector organizations. Clinical Reach, a Parallel 6 product, is an end-to-end patient centric engagement platform for the healthcare and life sciences industries. Clinical Reach enables clinical trial stakeholders to digitally recruit, eQualify, eConsent and engage clinical trial participants through their patented platform. Additional solutions include GovReach for government agencies and Captive Reach for corporate organizations that influence consumer behavior, enhance brand recognition and build strong, client-customer relationships through push notifications, gamification strategies and more. The firm is headquartered in San Diego with federal offices in Washington D.C. For more information, visit http://www.parallel6.com/.

advertisement | advertise on newsday

For the original version on PRWeb visit: http://www.prweb.com/releases/2015/10/prweb13037595.htm